Results 331 to 340 of about 622,897 (403)

The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice. [PDF]

Respir Res
Colunga-Biancatelli RML, Solopov PA, Woodson CM, Allen IC, Akhrymuk I, Akhrymuk M, Heath BN, Ivester HM, Day T, Austin DE, Kehn-Hall K, Lazo JS, Sharlow ER, Catravas JD.   +13 more
europepmc   +1 more source

Respiratory Syncytial Virus Exceeded SARS‐CoV‐2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023–2024 Respiratory Virus Season

Transplant Infectious Disease, EarlyView.
During the 2023‐2024 respiratory viral season, respiratory syncytial virus infection was associated with worse outcomes compared to infections caused by SARS‐CoV‐2 and influenza virus in patients with hematologic malignancies ABSTRACT Background Respiratory viral infections (RVIs) significantly impact patients with hematologic malignancies (HMs ...
Tali Shafat, Amy Spallone, Fareed Khawaja, Ying Jiang, Jennifer Jackson, Lior Nesher, Roy F. Chemaly   +6 more
wiley   +1 more source

Hepatitis B virus associated with severe acute respiratory syndrome coronavirus 2 infection: a case report. [PDF]

J Med Case Rep
Florea CE, Bălaș-Maftei B, Obreja M, Rotaru A, Irimie-Băluță ER, Manciuc C.   +5 more
europepmc   +1 more source

Molecular Respiratory Pathogen Panels in Lung Transplantation

Transplant Infectious Disease, EarlyView.
ABSTRACT Molecular respiratory pathogen panels are an innovative tool for the rapid detection of respiratory pathogens and antimicrobial resistance genes, offering the potential to improve diagnostic accuracy and guide timely antimicrobial therapy.
Andrea Lombardi
wiley   +1 more source

Trends in Group A <i>Streptococcus</i> Pharyngitis and Co-Infection with Severe Acute Respiratory Syndrome Coronavirus 2: A Retrospective Observational Study. [PDF]

Medicina (Kaunas)
Takahashi H, Satake Y, Shimizu S, Fujihara S, Takano S, Fukasawa S, Park K, Toba N, Yano T, Nagamatsu H, Hirose R, Toyama-Kousaka M, Ota S, Morikawa M, Shinkai M.   +14 more
europepmc   +1 more source

Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant Recipients

Transplant Infectious Disease, EarlyView.
ABSTRACT Background Respiratory viral infections (RVIs) can have distinct clinical presentations and outcomes in non‐lung solid organ transplant (SOT) recipients compared to non‐transplant and lung transplant patients. Understanding their impact is crucial for improving patient care and outcomes.
Manon L. M. Prins, Ernst D. van Dokkum, Aiko P. J. de Vries, Maarten E. Tushuizen, Danny van der Helm, Edwin M. Spithoven, Irene M. van der Meer, Eduard M. Scholten, Albert M. Vollaard, Saskia le Cessie, Leo G. Visser, Geert H. Groeneveld   +11 more
wiley   +1 more source

Critical illness in immunocompromised patients: insights into relapse or persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): case series report. [PDF]

J Med Case Rep
Hernández-Ortiz OH, Llano JF, Sánchez AM, Jaimes F, Moreno AM, Perez-Restrepo LS, Usuga J, Camacho E, Osorio JE, Hernández-Ortiz JP.   +9 more
europepmc   +1 more source

Stewardship of Molecular Diagnostics in Transplant Viral Infections

Transplant Infectious Disease, EarlyView.
ABSTRACT The transplant environment requires special considerations when testing for viral infections as immunosuppression results in atypical infection profiles. Microbes otherwise considered commensals or causing mild disease can lead to severe infections in transplant environments. Therefore, guidelines tend to recommend broader microbial testing in
Scott Sugden, David Reynoso, Reema Mathew, Michael Loeffelholz   +3 more
wiley   +1 more source

Autoantibodies in COVID‐19 convalescent plasma donors

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Although COVID‐19 convalescent plasma (CCP) has been successfully used to treat several viral infections, its effectiveness in neutralizing severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and its broader immunological safety remain debated.
Katerina Jazbec Gradišar, Klemen Žiberna, Polonca Mali, Ivica Marić, Primož Rožman, Elvira Maličev   +5 more
wiley   +1 more source

Women in space: A review of known physiological adaptations and health perspectives

Experimental Physiology, EarlyView.
Abstract Exposure to the spaceflight environment causes adaptations in most human physiological systems, many of which are thought to affect women differently from men. Since only 11.5% of astronauts worldwide have been female, these issues are largely understudied.
Millie Hughes‐Fulford, Danielle J. Carroll, Heather C. M. Allaway, Bonnie J. Dunbar, Aenor J. Sawyer   +4 more
wiley   +1 more source